LIFE09200604007 Tabish - Homi Bhabha National Institute

Bibliography
22. Billroth, T., Die Allgemeine Chirurgische Pathologie und Therapie in 51 Vorlesungen. In:
Handbuch fur Studierende and Artze, 14. Berlin: Auflage. 1889, 908.
23. Warren S.; Gates, O., Multiple primary malignant tumors: a survey of the literature and a
statistical study. Am J Cancer 1932, 16, 1358-1414.
24. Day, G. L.; Blot, W. J., Second primary tumors in patients with oral cancer. Cancer 1992, 70, (1),
14-9.
25. Luo, G.; Santoro, I. M.; McDaniel, L. D.; Nishijima, I.; Mills, M.; Youssoufian, H.; Vogel, H.;
Schultz, R. A.; Bradley, A., Cancer predisposition caused by elevated mitotic recombination in
Bloom mice. Nat Genet 2000, 26, (4), 424-9.
26. Kupfer, G. M.; Naf, D.; D'Andrea, A. D., Molecular biology of Fanconi anemia. Hematol Oncol
Clin North Am 1997, 11, (6), 1045-60.
27. Tonin, P. N., Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 2000,
18, (4), 281-6.
28. Varley, J. M., Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003, 21, (3),
313-20.
29. Slaughter, D. P.; Southwick, H. W.; Smejkal, W., Field cancerization in oral stratified squamous
epithelium; clinical implications of multicentric origin. Cancer 1953, 6, (5), 963-8.
30. Braakhuis, B. J.; Tabor, M. P.; Kummer, J. A.; Leemans, C. R.; Brakenhoff, R. H., A genetic
explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Cancer Res 2003, 63, (8), 1727-30.
31. Hanahan, D.; Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011, 144, (5), 646-
74.
32. Smith, E. M.; Rubenstein, L. M.; Haugen, T. H.; Pawlita, M.; Turek, L. P., Complex etiology
underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a
case for multifactor disease. J Oncol 2012, 2012, 571862.
33. Fan, C. Y., Genetic alterations in head and neck cancer: interactions among environmental
carcinogens, cell cycle control, and host DNA repair. Curr Oncol Rep 2001, 3, (1), 66-71.
34. Yamasaki, H.; Mironov, N., Genomic instability in multistage carcinogenesis. Toxicol Lett 2000,
112-113, 251-6.
35. Baez, A., Genetic and environmental factors in head and neck cancer genesis. J Environ Sci
Health C Environ Carcinog Ecotoxicol Rev 2008, 26, (2), 174-200.
36. Doll, R., Pott and the path to prevention. Arch Geschwulstforsch 1975, 45, (6), 521-31.
37. Cogliano, V. J.; Baan, R.; Straif, K.; Grosse, Y.; Lauby-Secretan, B.; El Ghissassi, F.; Bouvard,
V.; Benbrahim-Tallaa, L.; Guha, N.; Freeman, C.; Galichet, L.; Wild, C. P., Preventable
exposures associated with human cancers. J Natl Cancer Inst 2011, 103, (24), 1827-39.
38. Olshan, A. F.; Weissler, M. C.; Watson, M. A.; Bell, D. A., GSTM1, GSTT1, GSTP1, CYP1A1,
and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol
Biomarkers Prev 2000, 9, (2), 185-91.
39. Houlston, R. S.; Peto, J., The search for low-penetrance cancer susceptibility alleles. Oncogene
2004, 23, (38), 6471-6.
40. Kotnis, A.; Namkung, J.; Kannan, S.; Jayakrupakar, N.; Park, T.; Sarin, R.; Mulherkar, R.,
Multiple pathway-based genetic variations associated with tobacco related multiple primary
neoplasms. PLoS One 7, (1), e30013.
41. Li, F.; Sturgis, E. M.; Chen, X.; Zafereo, M. E.; Wei, Q.; Li, G., Association of p53 codon 72
polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma
of the head and neck. Cancer 2010, 116, (10), 2350-9.
42. Lei, D.; Sturgis, E. M.; Wang, L. E.; Liu, Z.; Zafereo, M. E.; Wei, Q.; Li, G., FAS and FASLG
genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma
of the head and neck. Cancer Epidemiol Biomarkers Prev 2010, 19, (6), 1484-91.
150